glp 1 dpp 4 pathway GLP-1 receptor agonists or DPP-4 inhibitors: How to guide the clinician? JCI Insight - Hepatocyte-derived DPP4

Xu says losing too much lean mass may weaken pelvic floor support

JDDG: J Der Deutschen Dermatologischen Gesellschaft

Biochimica et Biophysica Acta (BBA)-General subjects, 1830

However, metoclopramide carries a black-box warning for tardive dyskinesia with prolonged use (beyond 12 weeks), so it's reserved for short-term rescue during the worst escalation weeks

In the 72-week study of more than 1,600 overweight or obese adults with Type 2 diabetes, those who received the 36-milligram highest dose of orforglipron on average shed 10.5% of their weight, or about 23 pounds, versus 2.2% for those who received a placebo, achieving the main goal of the trial